Granules India Ltd: Webinar Transcript on Growth Strategy

Granules India Ltd has released the transcript of a webinar held on September 29, 2026, detailing their "Granules India 2.0 Comprehensive Transformation Underway". The company outlined four key growth engines: controlled substances, complex generics and early market opportunities, oncologies, and peptide CDMO. These initiatives are built upon existing capabilities and aim to drive future growth across diverse products and markets. The strategy focuses on developing higher-value products, expanding geographic reach, and improving the portfolio mix, with a goal to translate investments into a substantially larger business with faster earnings growth over the next three to four years, while maintaining financial discipline. The company highlighted a shift towards a "3 first-to-file playbook" in R&D, emphasizing technical complexity, unmet patient needs, and market economics over sheer volume of filings. This has led to a significant increase in complex generics' contribution to revenue.